Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase

NCT00451035 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia in Chronic Phase

Interventions

DRUG: LBH589

Sponsor

Novartis Pharmaceuticals